Blocking the IL-1β signalling pathway prevents chronic viral myocarditis and cardiac remodeling

The immunoproteasome‐specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis

(2018) Nadine Althof et al.   EMBO Molecular Medicine

Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis

(2018) Kathleen Pappritz et al.   FASEB JOURNAL

Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases

(2018) Giacomo Emmi et al.   Current Cardiology Reports

IL-1β reduces cardiac lymphatic muscle contraction via COX-2 and PGE2 induction: Potential role in myocarditis

(2018) Mahmoud Al-Kofahi et al.   BIOMEDICINE & PHARMACOTHERAPY

Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis

(2017) Federico Parisi et al.   MEDICINE

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure

(2017) Giulio Cavalli et al.   Frontiers in Immunology

Treating Life-Threatening Myocarditis by Blocking Interleukin-1*

(2016) Giulio Cavalli et al.   CRITICAL CARE MEDICINE

Tenascin-C May Accelerate Cardiac Fibrosis by Activating Macrophages via the Integrin αVβ3/Nuclear Factor–κB/Interleukin-6 AxisNovelty and Significance

(2015) Naoshi Shimojo et al.   HYPERTENSION

The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1β

(2015) Jean-Michel Rondeau et al.   mAbs

Viral myocarditis—diagnosis, treatment options and current controversies

(2015) Ari Pollack et al.   Nature Reviews Cardiology

The activating receptor NKG2D of natural killer cells promotes resistance against enterovirus-mediated inflammatory cardiomyopathy

(2014) Karin Klingel et al.   JOURNAL OF PATHOLOGY

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

(2013) A. L. P. Caforio et al.   EUROPEAN HEART JOURNAL

Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts

(2013) Sheng Zhao et al.   Journal of Cardiology

Matricellular Proteins in Cardiac Adaptation and Disease

(2012) Nikolaos G. Frangogiannis   PHYSIOLOGICAL REVIEWS

Macrophage-Stimulated Cardiac Fibroblast Production of IL-6 Is Essential for TGF β/Smad Activation and Cardiac Fibrosis Induced by Angiotensin II

(2012) Feifei Ma et al.   PLoS One

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

(2011) C. A. Dinarello   BLOOD

Regulating Viral Myocarditis: Allografted Regulatory T Cells Decrease Immune Infiltration and Viral Load

(2010) David J. Marchant et al.   CIRCULATION

Interleukin-17A Is Dispensable for Myocarditis but Essential for the Progression to Dilated Cardiomyopathy

(2010) G. Christian Baldeviano et al.   CIRCULATION RESEARCH

Interleukin-1 (IL-1) Pathway

(2010) A. Weber et al.   Science Signaling

Critical Role for IL-6 in Hypertrophy and Fibrosis in Chronic Cardiac Allograft Rejection

(2009) J. A. Diaz et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Immunological and Inflammatory Functions of the Interleukin-1 Family

(2009) Charles A. Dinarello   Annual Review of Immunology

Osteopontin

(2009) Gudrun Szalay et al.   CIRCULATION RESEARCH

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

(2009) A. Frustaci et al.   EUROPEAN HEART JOURNAL

Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity

(2008) O. Osborn et al.   CYTOKINE